SCHEMBL19176281

SCHEMBL19176281

C=CC(O)N1CCCOCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CCC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 20/20 0.62
▸ LYN P07948 3/20 0.62
▸ LCK P06239 2/20 0.62
▸ EGFR P00533 4/20 0.62
▸ TEC P42680 3/20 0.62
▸ BMX P51813 3/20 0.62
▸ TXK P42681 2/20 0.62
▸ FGFR2 P21802 2/20 0.62
▸ ITK Q08881 2/20 0.62
▸ BLK P51451 2/20 0.62
▸ NUDT14 O95848 2/20 0.62
▸ NUDT5 Q9UKK9 2/20 0.62
▸ RIPK2 O43353 1/20 0.62
▸ NR1I2 O75469 1/20 0.62
▸ SLC22A3 O75751 1/20 0.62
▸ LATS1 O95835 1/20 0.62
▸ ABL1 P00519 1/20 0.62
▸ ERBB2 P04626 1/20 0.62
▸ FYN P06241 1/20 0.62
▸ PGR P06401 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18493108 0.90 BTK (0.73) BTKLYNLCKEGFRTEC
SCHEMBL21398244 0.90 BTK (0.73) BTKLYNLCKEGFRTEC
SCHEMBL20223313 0.85 BTK (0.72) BTKLYNLCKEGFRTEC
SCHEMBL19519589 0.81 BTK (0.71) BTKLYNLCKEGFRTEC
SCHEMBL19831569 0.80 BTK (0.70) BTKLYNLCKEGFRTEC
SCHEMBL22625403 0.79 BTK (0.71) BTKLYNLCKEGFRTEC
SCHEMBL4910818 0.79 BTK (0.79) BTKLYNLCKEGFRTEC
SCHEMBL23409076 0.78 BTK (0.74) BTKLYNLCKEGFRTEC
SCHEMBL24827796 0.78 BTK (0.74) BTKLYNLCKEGFRTEC
SCHEMBL6431516 0.78 BTK (1.00) BTKLYNLCKEGFRTEC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017124657-A1 BRUTON'S TYROSINE KINASE INHIBITOR HAVING SPIRAL OR BRIDGED RING STRUCTURE AND PREPARATION METHOD THEREOF 成都倍特药业有限公司 2017-07-27 — — WO disclosed
Send feedback